Shanthikumar, S, Ranganathan, S, Neeland, MR. Ivacaftor, not ivacaftor/lumacaftor, associated with lower pulmonary inflammation in preschool cystic fibrosis.. Pediatr Pulmonol 57(10) : 2549 -2552 2022
view publication
Du Berry, C, Nesci, C, Cheong, JLY, FitzGerald, T, Mainzer, R, Ranganathan, S, Doyle, LW, Vrijlandt, EJLE, Welsh, L. Long-term expiratory airflow of infants born moderate-late preterm: A systematic review and meta-analysis.. EClinicalMedicine 52: 101597 2022
view publication
Kim, S, Collins, G, Giraldo, DM, Giacalone, V, Shanthikumar, S, Rao, P, Ranganathan, S, Stick, S, Tirouvanziam, R, Chandler, J. 386 Association between myeloperoxidase activity and methionine oxidation products in bronchoalveolar lavage and risk of bronchiectasis in infants and toddlers with cystic fibrosis. Journal of Cystic Fibrosis 21: s226 2022
view publication
Giraldo, DM, Giacalone, V, Shanthikumar, S, Ranganathan, S, Rao, P, Stick, S, Chandler, J, Esther, C, Tirouvanziam, R. 414 Longitudinal analysis of early-life bronchoalveolar fluid identifies immune mediators associated with bronchiectasis risk in children with cystic fibrosis. Journal of Cystic Fibrosis 21: s240 2022
view publication
Shanthikumar, S, Kim, S, Giacalone, V, Rao, P, Ranganathan, S, Karpievitch, Y, Stick, S, Boucher, R, Tirouvanziam, R, Chandler, J, et al. 446 Metabolites in early life bronchoalveolar fluid associate with future bronchiectasis risk in children with cystic fibrosis. Journal of Cystic Fibrosis 21: s256 2022
view publication